SUPRIYAPharmaceuticals
Supriya Lifescience Ltd — PE Ratio & Valuation Analysis
₹561.90
-1.58%
Current P/E32.91xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E30.7x7.1% above avg
⚠️
3.6% Premium to Industry
SUPRIYA P/E 32.91x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹23.35 | ₹752 | 32.2x |
| 2024 | ₹14.80 | ₹740 | 50x |
| 2023 | ₹11.16 | ₹315 | 28.2x |
| 2022 | ₹18.86 | ₹235 | 12.5x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Supriya Lifescience Ltd Valuation
Supriya Lifescience Ltd (SUPRIYA) currently trades at 32.91x earnings. The Pharmaceuticals sector average PE is 31.77x. SUPRIYA commands a premium, reflecting high growth expectations. Historically, SUPRIYA has traded at an average PE of 30.7x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
20.75%
Dividend Yield
0.13%
More on Supriya Lifescience Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.